Amplified Engineering

Progenis Pharmaceuticals, located in Bentley, Western Australia, is at the forefront of developing next-generation RNA therapeutics aimed at enhancing patient outcomes globally. The company specializes in precision RNA therapy, utilizing advanced antisense oligonucleotides to effectively target and regulate disease-causing proteins. Driven by a commitment to innovation, Progenis Pharmaceuticals focuses on groundbreaking treatments for a diverse range of acquired and genetic illnesses. Their team of renowned experts is dedicated to transforming how diseases are treated, striving for safer and more effective therapeutic solutions. Generated from the website

Recce Pharmaceuticals Ltd, located in Bentley, Western Australia, is at the forefront of developing innovative synthetic anti-infectives aimed at combating the global health crisis posed by antibiotic-resistant superbugs. Their proprietary products target both bacteria and viruses, featuring a universal mechanism of action that maintains potency even with repeated use, addressing significant medical needs in the field of infectious diseases. The company's pipeline includes multiple clinical candidates in Phase III trials, including a registrational trial in Indonesia, showcasing a commitment to providing therapeutic options for challenging bacterial infections and their mutated forms. Recce Pharmaceuticals is dedicated to enhancing its product offerings to effectively tackle difficult infections that are resistant to existing treatments. Generated from the website